INTERESTS: Biological Psychiatry, Neuropsychopharmacology, Psychiatry applied Neurosciences, Psychiatric classification and addictions.
Social Networks: CV
Schizophrenia: Neurobiology and Therapeutic.
In this lecture we show the last advances in the field of Schizophrenia. The new developments with regard to the dopaminergic, serotoninergic, glutamatergic and gabaergic systems. We make a analysis of the new drugs in the market, the new D2 and 5HT2 blockers and the new long acting injections. Their impact about the quality of the patient´s life.